Biogen Idec expands its operation in Denmark  

2006.02.08
US biotech firm Biogen Idec, whose production facility in Denmark is the first of its kind outside of the US, is gearing up to employ another 100 staff

US biotech firm Biogen Idec, whose production facility in Denmark is the first of its kind outside of the US, is gearing up to employ another 100 staff to work in the quality assurance laboratory and packing facility which will soon be under construction and is expected to be complete next year.

The packaging facility will be handling despatch of Biogen Idec's sclerosis product Tysabri to 93 countries – which corresponds to the company's entire export market outside the US.

Biogen Idec is a global biotechnology leader with products and capabilities in oncology, neurology and immunology. Biogen Idec is headquartered in Cambridge, MA, and was formed in 2003 from the merger of two of the world's leading biotech companies Biogen and IDEC Pharmaceuticals Corporation. The company employs approx. 3,400 people worldwide.

Link > Biogen Idec

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×